References
- Shoenfeld Y., Schwartz R. S. Immunologic and genetic factors in autoimmune diseases. New. Eng. J. Med. 1984; 311: 1019–1028
- Namba T., Brown S. B., Grob D. Neonatal myasthenia gravis: report of two cases and review of literature. Pediatrics 1970; 45: 488–504
- Lefvert A. K., Osterman P. O. Newborn infants to myas-thenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children. Neurology 1983; 33: 133–138
- Lefvert A. K. Auto-anti-idiotypie immunity and acetylcholine receptors. Concepts in immunopathology-immunoregulation, J. M. Cruse. Karger, Basel 1986; vol 3: 285–310
- Holmdahl R., Jansson L., Larsson A., Jonsson R. Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and scrum levels of anti-type II collagen auto-antibodies. Scand. J. Immunol. 1990; 31: 147–157
- Parekh R. B., Dwek R. A., Sutton B. J., Fernandas D. L., Leung A., Stanworth D. R., et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total scrum IgG. Nature 1985; 316: 452–457
- Rademacher T., Parekh R. B., Dwek R. A., Isenberg D., Rook G. A. W., Axford J. S., et al. The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis. Springer Semin. Immunopathol. 1988; 10: 231–249
- Rook G. A. W., Steele J., Brealey R., Whyte A., Isenberg D., Sumar N., et al. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J. Autoimm. 1991; 4: 779–794
- Thompson S. J., Hitsumoto Y., Zhang Y. W., Rock G. A. W., Elson C. J. Agalactosyl IgG in pristane-induced arthritis II. Pregnancy affects the incidence and severity of the arthritis and the galactosylation status of the IgG. Clin. Exp. Immunol. 1992; 89: 434–438
- Rademacher T. W. Network theory of glycosylationactiologic and pathogenic implication of changes in IgG glycoform levels in autoimmunity. Semin. Cell. Biol. 1991; 2: 327–337
- Rademacher T. W., Williams P., Dwek R. A. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl Acad. Sci. USA. 1994; 91: 6123–6127
- Lefvert A. K., Bergstrom K., Matell G., Osterman P. O., Pirskanen R. Determination of acetylcholine receptor antibodies in myasthenia gravis: Clinical usefulness and pathogenetic implications. J. Neurol. Neursurg. Psychiat. 1978; 41: 394–403
- Rook G. A. W., Steele J., Rademacher T. A monoclonal antibody raised by immunising mice with group A streptococci binds to agalactosyl IgG from rheumatoid arthritis. Ann. Rheum. Dis. 1988; 47: 247–250
- van Zeben D., Rook G. A. W., Hazes J. M. W., Zwinderman A. H., Zhang Y., Ghelani S., et al. Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Brit. J. Rheumatol. 1994; 33: 36–43
- McCulloch J., Zang Y. W., Dawson M., Harkiss G. D., Peterhans H., Vogt H. R., et al. Glycosylation of IgG during potentially arthritogenic lentiviral infections. Rheumatol. Int. 1995; 14: 243–248
- Parekh R., Isenberg D., Roitt I., Dwek R., Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human scrum IgG. J. Exp. Med. 1988; 167: 1731–1736
- Rook G. A. W., Thompson S., Buckley M., Elson C., Brealey R., Lambert C., et al. The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur. J. Immunol. 1991; 21: 1027–1032
- Janeway C. A. Immunogenicity signals 1,2,3. … and 0 (news). Immunology Today 1989; 10: 283–286